Biodefense Market by Product (Anthrax, Botulism, Radiation), End-User (Ambulatory Care Centers, Hospitals, Military) - Global Forecast 2024-2030

360iResearch Analyst
Want to know more about the biodefense market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[186 Pages Report] The Biodefense Market size was estimated at USD 18.36 billion in 2023 and expected to reach USD 20.33 billion in 2024, at a CAGR 11.25% to reach USD 38.73 billion by 2030.

Biodefense Market
To learn more about this report, request a free PDF copy
Biodefense Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biodefense Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biodefense Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biodefense Market, highlighting leading vendors and their innovative profiles. These include Alnylam Pharmaceuticals, Inc., Altimmune, Inc., Bavarian Nordic A/S, BDO USA, LLP, Bharat Biotech Ltd., Dynport Vaccine Company by General Dynamics Information Technology, Elusys Therapeutics, Inc. by Heat Biologics Inc., Emergent BioSolutions Inc., Evogen, Inc., Ichor Medical Systems, Inc., Pizer Inc., Serum Institute of India Pvt. Ltd., SIGA Technologies, Soligenix, Inc., and Xoma Corporation.

Market Segmentation & Coverage

This research report categorizes the Biodefense Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Anthrax
    • Botulism
    • Radiation
    • Small Pox
  • End-User
    • Ambulatory Care Centers
    • Hospitals
    • Military
    • Research Organizations

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Biodefense Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biodefense Market?
  3. What are the technology trends and regulatory frameworks in the Biodefense Market?
  4. What is the market share of the leading vendors in the Biodefense Market?
  5. Which modes and strategic moves are suitable for entering the Biodefense Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Biodefense Market, by Product
  7. Biodefense Market, by End-User
  8. Americas Biodefense Market
  9. Asia-Pacific Biodefense Market
  10. Europe, Middle East & Africa Biodefense Market
  11. Competitive Landscape
  12. Competitive Portfolio
  13. List of Figures [Total: 20]
  14. List of Tables [Total: 200]
  15. List of Companies Mentioned [Total: 15]
Biodefense is the next big national strategy of the United States
February 7, 2023
Biodefense is the next big national strategy of the United States
Federal and state governments in the United States are on their way to preparing for future biological threats holding up the objectives of national and global biodefense.

The National Biodefense Strategy, introduced in October 2022, outlines a national vision for managing challenges from inherently occurring, intentional, or unexpected biological threats. Ebola, Anthrax, and pandemic preparedness strategies propel the need for transformative improvements in the country’s capabilities to deter, detect, and react to arising biological cataclysms.

Biological incidents have been a costly threat to the U.S., impacting thousands of American lives and disrupting travel and trade. New strategies aid in keeping up the legacy of biodefense research in the country by highlighting advances on specific viral pathogens to summarize the future of biodefense investigations.

In 2021, New York unveiled its USD 40 million Biodefense Commercialization Fund, to expand and commercialize life science research and innovations that discourse severe contagious health hazards, including COVID-19 and its variants.

The U.S. Agency for International Development (USAID) and the federal government's aim to revitalize critical infrastructure services, coordinate recuperation actions, and focus on long-term mitigation of any biological threats coming their way.

With China and Russia proliferating their investments in biodefense and the EU and India revolutionizing research, the U.S. is rapidly proposing funding and development activities to remain on track.

Frequently Asked Questions
  1. How big is the Biodefense Market?
    Ans. The Global Biodefense Market size was estimated at USD 18.36 billion in 2023 and expected to reach USD 20.33 billion in 2024.
  2. What is the Biodefense Market growth?
    Ans. The Global Biodefense Market to grow USD 38.73 billion by 2030, at a CAGR of 11.25%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.